The low‐dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Increasing evidence favours subtle glucocorticoid excess in many patients with adrenal incidentalomas. However, existing evidence is based mainly on the overnight dexamethasone suppression test, a test that is commonly abnormal even among clinically euadrenal subjects. The aim of the present study was to evaluate patients with adrenal incidentalomas for subtle glucocorticoid excess by the more specific low‐dose dexamethasone test (LDDST). Moreover, since the criteria of what constitutes an abnormal cortisol response following this test have been largely anecdotal, we report our results in comparison with those obtained in clinically euadrenal subjects, and patients with Cushing's syndrome. DESIGN: A prospective study of 57 patients with adrenal incidentalomas with CT characteristics highly suggestive of benign adrenocortical adenomas and 85 clinically euadrenal subjects consisting of 54 obese women with BMI > 30 kg/m 2 (range 30–54.7), 13 women with BMI < 30 kg/m 2 (range 20.3–29.6) and 18 healthy volunteers (10 women and eight men) over 40 years of age (mean age 51.7 ± 9.9, range 40–74; mean BMI 30 ± 6.6, range 20.3–47.5 kg/m 2). A retrospective analysis was performed on 60 patients with a confirmed diagnosis of Cushing's syndrome. MEASUREMENTS: All subjects were admitted to the endocrine ward and underwent a standard LDDST, as follows: after a 48‐h stabilization period, a 24‐h urine collection for basal urinary free cortisol was performed. Basal serum cortisol and plasma ACTH were measured at 0800 h the following day, and subjects were started on dexamethasone 0.5 mg 6‐hourly for 2 days. Post‐dexamethasone cortisol and ACTH levels were measured at 0800 h, 6 h after the last dose of dexamethasone. RESULTS: Following dexamethasone suppression serum cortisol concentrations became undetectable (<28 nmol/l) in all clinically euadrenal subjects. In patients with incidentally discovered adrenal masses, post‐LDDST cortisol concentrations were undetectable in 12 (21%), between 28–140 nmol/l in 38 (67%), and 140–216 nmol/l in seven (12%) patients; post‐LDDST cortisol values correlated positively with the size of the adenoma (r = + 0.482, P < 0.001). Post‐LDDST cortisol concentrations in patients with Cushing's syndrome ranged from 85 to 1786 nmol/l; in 3/42 (7%) patients with ACTH‐dependent Cushing's syndrome cortisol concentrations were <140 nmol/l. CONCLUSIONS: On the basis of our data in a large group of clinically euadrenal subjects, we suggest that following LDDST cortisol concentrations should become undetectable with the currently used radioimmunoassays. In patients with adrenal incidentalomas, application of the LDDST confirmed the presence of incomplete suppression of cortisol in the majority of patients. We suggest that the LDDST is a sensitive index of autonomous cortisol production in patients with adrenal incidentalomas; following this test a grading of subtle glucocorticoid excess may be obtained but future studies correlating biochemical, clinical and epidemiological data are required, in order to develop widely agreed cut‐off levels of clinically significant glucocorticoid excess in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393 · cited 2×
“Thus, urinary free cortisol (UFC) excretion is an insensitive test, with false negative rates ranging from 5% to 11% even in patients with overt Cushing's syndrome (Crapo, 1979; Trainer & Grossman, 1991).”
BackgroundResultEndocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients
Kasperlik‐Załuska, A. A., Rosłonowska, E., Słowińska‐Srzednicka, J., Migdalska, B., Jeske, W., Makowska, A., & Snochowska, H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1751.x · Cited by 155
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136 · cited 4×
“…decreased ACTH responsiveness to CRH and excessive urinary cortisol excretion have been detected with a decreasing order of frequency (Virkkala et al., 1989; Jockenhovel et al., 1992; Reincke et al., 1992; Osella et al., 1994; Ambrosi et al., 1995; Flecchia et al., 1995; Kasperlik-Zaluska, 1997).”
BackgroundMethodInfluentialFlecchla, D., Mazza, E., Carllni, M., Blatto, A., Ollvlerl, F., Serra:, G., Camannl, F., & Messlna, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01852.x · Cited by 75 · cited 1×
“…decreased ACTH responsiveness to CRH and excessive urinary cortisol excretion have been detected with a decreasing order of frequency (Virkkala et al., 1989; Jockenhovel et al., 1992; Reincke et al., 1992; Osella et al., 1994; Ambrosi et al., 1995; Flecchia et al., 1995; Kasperlik-Zaluska, 1997).”
BackgroundBardet, S., Rohmer, V., Murat, A., Guillemot, C., Maréchaud, R., Chupin, M., Lecomte, P., Simon, D., Delemer, B., Schneebelli, S., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.720541.x · Cited by 71
Kennedy, L., Atkinson, A. B., Johnston, H., Sheridan, B., & Hadden, D. R. (1984) · BMJ · doi:10.1136/bmj.289.6453.1188 · Cited by 67 · cited 1×
“We are aware of only two previous studies suggesting divergent cut-off points (of 140 and 60 nmol/ l, respectively) as indicating an abnormal result (Aschraft et al., 1982; Kennedy et al., 1984).”
Background
Cited by
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
Cawood, T. J., Hunt, P. J., O'Shea, D., Cole, D., & Soule, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0234 · Cited by 300
Metadata
- Authors
- Tsagarakis, S., Kokkoris, P., Roboti, C., Malagari, C., Kaskarelis, J., Vlassopoulou, V., Alevizaki, C., & Thalassinos, N.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1998-05
- Volume
- 48
- Issue
- 5
- Pages
- 627-633
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2024017222
- Cited by
- 63
- References
- 8
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The low‐dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00464.x
- The paper
- Tsagarakis, S., Kokkoris, P., Roboti, C., Malagari, C., Kaskarelis, J., Vlassopoulou, V., Alevizaki, C., & Thalassinos, N. (1998). The low‐dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00464.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.